Promising New Drug May Effectively Treat Chagas Disease
After more than 50 years, researchers have discovered a potential treatment for Chagas disease that has shown promise in non-human primate trials.
Stay updated with breaking news from Nat Microbiol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After more than 50 years, researchers have discovered a potential treatment for Chagas disease that has shown promise in non-human primate trials.
Investegate announcements from AstraZeneca PLC, Evusheld approved for COVID-19 in Japan
Here, Thomas Rademacher of Emergex Vaccines explains how delivery of virus-specific major MHC class I epitopes to the skin-resident immune system can translate to the presence of antigen-specific memory T-cells at distal sites.
Detailed results from the TACKLE Phase III outpatient treatment trial showed AstraZeneca’s Evusheld (tixagevimab and cilgavimab, formerly AZD7442) provided clinically and statistically significant protection against progression to severe COVID-19 or death from any cause compared to placebo, with treatment with ...